Precision AQ’s Post

What's in a name? A lot if you ask us. Introducing: Precision AQ. It's a nod to our mission, empowering access to life-changing medicine for all, but also our approach. IQ + EQ = Precision Access Quotient (AQ). We've fused together the science 🧪 (IQ) and empathy ❤️ (EQ) of nine diverse organizations into one brand to offer greater access to the services, data, expertise, and scale needed to navigate the therapy-to-patient journey. Learn more about our new blueprint for access: https://lnkd.in/gvB9eCJh

Commercial drug development requires special expertise – and we believe ER physicians deserve a spot at the table. Ross Maclean, EVP, Head of Medical Affairs and Linda Goldenberg, DO, share how their unique skillset and real world practice can provide greater access to life-changing medicine for all in Med Ad News: https://hubs.ly/Q02G9wT40 #pharmaindustry #drugdevelopment

We are thrilled to be nominated for four PM Society Digital Awards 🎉 Our nominations in Brand Promotion, Customer Experience Excellence, and Film, Animation, and Video are a testament to the dedication and collaboration of our teams and partners. It is our strong combination of passion, creativity and expertise that enables us to do great work. This recognition belongs to all involved! Looking forward to the awards ceremony in September and wishing all nominees the best of luck! #PMSocietyDigitalAwards #pharmamarketing

At the heart of healthcare lies a simple truth: patients and their well-being. To achieve true patient centricity, we need to set a higher standard. The 2024 Good Patient Partnership Guide is filled with practical tips and inspiring approaches to keep patients at the core of everything we do. Download the guide: https://hubs.ly/Q02FNMDf0 #patientcentricity #healthcare #patientadvocacy #patientinformation #patientvoice #patientpartners #patientexperience #pharmaceuticalindustry

In case you missed it: Doug Fulling, President of Precision AQ, sat down with MM+M to discuss how we're dismantling barriers to empower patient access in healthcare. From launching 57% of the FDA-approved drugs in 2023 to navigating the complexities along the access continuum, our team blends science with empathy to ensure life-changing therapies reach those in need. Our unique approach is reshaping the access landscape, focusing on payers, providers, and patients alike. 🎧 Put on your headphones & listen to the insightful discussion: https://hubs.ly/Q02FyJbN0 #MMMAgency100 #healthcaremarketing #pharmamarketing

Even as a therapy enters the “late lifecycle,” medical affairs teams can’t slow down. Continuing to empower access to medicine years after launch can look like: ⚫ Continued evidence generation ⚫ Demonstrating the value against generic competition ⚫ Exploring broader use applications Ross Maclean, Head of Medical Affairs, and Uchenna Iloeje, MD share why and how med affairs teams can drive “safe and appropriate use” activities forward in a feature for Healthcare Business Today: https://lnkd.in/ei5Dhmgn #pharmaindustry #marketaccess #biopharma

It’s been a great month for Pride at Precision. We asked colleagues to snap selfies showing their pride, and for every picture submitted we made a donation to the The Trevor Project, a leading organization dedicated to ending suicide among LGBTQ+ youth, and to IGLA Europe, which fights for LGBTI equality and human rights across Europe and Central Asia. It’s another way we highlight support for our LGBTQIA+ friends, colleagues, and family members around the world. #Pride #PrideMonth #pride2024 #TrevorProject #IGLAEurope

Pharma manufacturers are stepping up to help patients afford their medications through patient assistance programs (PAPs). But how can companies ensure these programs truly benefit patients? Enabling access to life-changing medicine requires effective PAPs. Learn to tailor your PAPs, measure success, and navigate market factors with insights from our team - Lauren Westberg, EVP, Managing Director, Courtney L. Ottoson, SVP, Director of Client Services, and Andrew Cournoyer, SVP, Director of Access Experience Team – in MMIT (Managed Markets Insight & Technology): https://lnkd.in/ePb8uuWa #PAPs #patientexperience #patientaccess #healthequity

ASCO 2024 brought together thousands of minds and voices in oncology and life sciences. We captured the essence of these conversations to highlight pivotal moments and trends that defined the event. From groundbreaking research to inspiring stories, see what everyone was talking about online. Get our social listening report: https://lnkd.in/e4yi8_8Y #ASCO2024 #oncology #lifesciences #insights

"If you had the power to stop a disease before it started, you would, wouldn’t you?" Cynthia Miller, MD, MPH, CPH, FACP, VP, Medical Director and advocate for preventive care services, speaks about newfound research on lipid management medications on MedCity News. With support from healthcare providers, doctors, pharmaceutical companies, and EHR vendors, we could be on the brink of decreasing the development of and mortality from cardiovascular disease. https://lnkd.in/gZURVVUg